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In patients with aortic valve disease and normal coronary angiograms coronary reserve was determined by the coronary
sinus thermodilution technique. Three groups of patients were studied: 37 preoperative patients; 18 different patients
12-52 months after aortic valve replacement and seven control subjects with no cardiac disease. Coronary flow ratio
(dipyridamole/rest) was diminished in preoperative compared with postoperative patients (1-66±0-44 vs 2-22±0-85;
P<0-05) as well as with controls (2-80±0-84; P<0-01), and corresponding coronary resistance ratio (dipyridamolej
rest) was higher in preoperative patients than in both other groups (0-61±017 vs 0-48±014; P<005 vs 0-37±010;
P<0-01). Differences in the flow ratio, but not in the resistance ratio, were significant (P<0-05) in patients after aortic
valve replacement compared with controls. Total coronary sinus blood flow at rest was elevated in preoperative compared
with both postoperative patients and controls (252±99 vs 169±63; P<001; vs 170±35 ml.min~', P<005), whereas
flows after maximal vasodilation did not differ among the three groups (416± 184 vs 361 ± 150 vs 488± 235 ml.min'').
Postoperative patients showed a distinct, though not total regression of left ventricular angiographic muscle mass index and
wall thickness. Nine of the 18 postoperative patients showed a normal coronary flow reserve and nine showed subnormal
response. These two subgroups did not differ with respect to preoperative macroscopic and microscopic measures of
hypertrophy.
Thus in aortic valve disease, the reduced coronary vasodilator capacity is mainly due to an elevated coronary flow at rest,
while the maximal coronary blood flow achieved is identical to that of postoperative patients and controls. With regression
of left ventricular hypertrophy,flow at rest decreases and this leads to a distinct improvement of coronary flow reserve.
Introduction It has been shown1'71 that a normal coronary flow
Left ventricular hypertrophy induced by chronic pressure [ ^ f ™ c a .n * r<fored i n hypertensive rats byreversal of
and volume overload is associated with a reduced cor- e f} votfncular hypertrophy In man ,t has been estab-
onary flow reserve and vasodilator capacity™. These h s h e d * a t «gress.on of left ventricular hypertrophy
abnormalities of coronary dynamics are thought to be P*™* f o " o w i n 8 removal of an abnormal haemodynamic
major reasons for the occurrence of angina pectoris in * u r d e n ^ v a l v e "Placement' ' "• However, i t i s not
patients with aortic stenosis or insufficiency and normal k n o w n w h e t h e r c o r o n a r y flow, "serve and vasodilator
coronary arteries"10 '. Various mechanisms alone or in capacity improve postoperatively as well,
combination may lead to the reduced coronary flow re- ™ns'll w a s t h e P u r P ° * ° f t h l s s t u d y to investigate in
serve, as assessed by the ratio of maximally vasodilated P a t i e n t s ^ t h a 0 I ? c ,va"ve d i s e a s e a n d l e f f t . v e n t n c u l a r
and autoregulated basal flow. Maximal coronary flow hypertrophy whether (1) such improvements in coronary
may be depressed in hypertrophy as a consequence of a now reserve and vasod.lator capaaty do occur after valve
reduction of the vascular bed either functional, from "placement and (2) maximal vasodilated flow is mam-
extravascular compressive forces or structural, from tamed after regression ofleft ventncular hypertrophy. No
excess interstitial collagen formation with intercellular f^"*100 : n m a x i m a l «>«>"«* fl°w ^ u l d imply that the
scarring"11*. Alternatively, coronary flow reserve may lununal cross-sectional surface of the resistance vessels
be decreased in hypertrophy due to an increased flow at ^mamed ^ n u e n c e d by the regression process of the
rest with unchanged maximally achieved flow"^. This h vI*rtrophied myocardium,
encroachment on flow reserve by vasodilation at rest
becomes necessary because growth of the vessels through- M
 eH,ods
out the vascular tree does not keep pace with the increase
in ventricular mass"61. PATIENT POPULATION
Submitted for publication on 9 November 1989. and in revised form 18 April I " 0 " * &OUPS of patients Were Studied. At Cardiac cath-
1990. eterization all patients had a normal coronary angiogram
This work was supported by a grant of the Swiss Foundation of Cardiology. a n d W e r e i n s i n u S rhythm. Patients with aortic valve dis-
ease included in this study had no other concomitant valve
disease- The preoperative patient group consisted of 37
patients (nine women, 28 men; mean age 57 ± 10 years)
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who underwent cardiac catheterization for preoperative
evaluation of aortic valve disease, 28 of 37 presented with
predominant aortic stenosis, nine of 37 with predominant
aortic insufficiency. Ten patients with combined aortic
valve disease were classified as having aortic stenosis (n =
6) when aortic valve area was < 1 0 cm2 and as having
aortic insufficiency (n = 4) when the aortic valve area was
> 1 0 cm2. The postoperative patient group consisted of
18 patients (one women, 17 men, mean age 58 ±8 years)
who were studied 12-52 months (mean 30 months) after
successful aortic valve replacement. None were included
in the preoperative patient group. Aortic valve replace-
ment was carried out in 11 patients for aortic stenosis, in
seven for aortic insufficiency. Seven patients received a
mechanical prosthesis, 11 patients a bioprosthesis. Post-
operative patients selected for study were those followed
in this hospital and had their original (i.e. preoperative)
cardiac catheterization at this institution. All patients
demonstrated a good postoperative result without haemo-
dynamic compromise. The residual pressure gradient over
the aortic prosthesis was assessed by CW-Doppler echo-
cardiography in 16 of the 18 patients. It ranged from 4
to 36mmHg with a mean value of 18-7±7-4mmHg.
Patients agreed to undergo right heart catheterization on
a voluntary basis. The control group comprised seven
patients (two women, five men; mean age 50 ± 10 years)
evaluated for atypical chest pain. During upright bicycle
exercise testing ST-segment depression of more than
0-1 mV was found in four of these patients (two women,
two men; range 0-12—0-35 mV), but all patients showed a
normal physical working capacity of 97-104% of the
age-, sex and height-corrected normal value. Cardiac
catheterization revealed no cardiac disease, in particular
normal coronary arteries. However, no ergonovine test
was performed. Informed consent was obtained from all
patients under a protocol approved by the Human Studies
Committee of the University Hospital.
CARDIAC CATHETERIZATION
All cardiac medications were withheld for 12-24h
before catheterization. Premedication consisted of 10 mg
chlordiazepoxide (Librium®) given orally 1 h before the
procedure. The preoperative patients and the controls
underwent right and left heart catheterization. Aortic
pressure was measured through a fluid-filled 8F pigtail
catheter introduced through the right femoral artery.
In patients with aortic valve disease left ventricular press-
ure was obtained with a transseptally introduced 8-5F
Brockenbrough catheter. Right-sided pressures and pul-
monary capillary wedge pressure were measured with
a 7F Cournand catheter introduced through the right
femoral vein. In control patients right-sided pressures, but
not pulmonary capillary wedge pressure were obtained
using a 6F pacing catheter with a lumen for pressure
recordings. A peripheral lead of the standard electrocar-
diogram was recorded together with the pressure tracings.
Left ventricular cineangiography was performed in the
right and left anterior oblique projection. 40-50 ml of
the non-ionic cardiographic contrast iopamidol (755-2
mg.ml"1, trometamol 1 mg.ml~'=Iopamiro 370*) was
injected at a flow rate of 12 ml s ' . In the postoperative
patient group an ambulatory right heart catheterization
was performed. After the measurement of right-sided
pressures with a 7F Cournand catheter, an 8F pigtail
catheter was introduced in the pulmonary artery. Biplane
left ventricular angiography was obtained by injection of
radiographic contrast into the pulmonary artery (55 ml
at a flow rate of 18-20 ml s~'). With this technique a
left ventricular opacification was obtained of sufficient
quality for quantitative assessment of left ventricular
volumes and wall thickness.
Left ventricular volumes were calculated by the area-
length method'201 and left ventricular muscle mass
according to the method of Rackley et alPj\ Assuming a
thin-walled left ventricular ellipsoid model, end-diastolic
circumferential wall stress was calculated according to
the formula of Sandier and Dodge1221 and peak systolic
wall stress according to the method of Gaasch et al.l2i].
Aortic regurgitant fraction was determined by the thermo-
dilution technique or by comparison of cardiac output
calculated by means of angiography and the Fick method.
Values reported are values of thermodilution or average of
both methods. In postoperative patients arterial pressure
was measured with an arm sphygmomanometer and sys-
tolic cuff pressure was used instead of left ventricular
systolic pressure for calculation of systolic wall stress.
Left ventricular end-diastolic pressure was substituted by
mean pulmonary capillary wedge pressure for calculation
of end-diastolic stress in this latter patient group.
CORONARY BLOOD FLOW MEASUREMENTS
Measurement of coronary sinus blood flow was per-
formed following the diagnostic catheterization in all
preoperative patients and three controls. Four controls
were studied on an ambulatory basis with right heart
catheterization, at a mean of 10 days after diagnostic cor-
onary arteriography. Ventriculography was not repeated
in these four patients and therefore left ventricular vol-
umes and muscle mass reported are the values obtained at
the diagnostic catheterization. Total coronary blood flow
was measured by the coronary sinus thermodilution tech-
nique1241. A 7F thermodilution catheter (CCS-7U-90 A or
B, Webster Laboratory, Altadena, CA) was introduced
from the right femoral or in a few cases from the right
antecubital vein and advanced 2 cm into the coronary
sinus. Correct positioning was checked by measuring
oxygen saturation and by injection of small amounts of
contrast dye before and after measurements and docu-
mented by angiography. Injection of cold saline into the
superior vena cava was not associated with changes in
the temperature curve of the thermistor in the coronary
sinus1231. The signals of the external (mixing temperature
of blood and saline) and internal (temperature of the
injected saline) thermistors were recorded on an 'Elec-
tronics for Medicine VR-12 ' oscillograph at a paper
speed of 5mm.s~'. Saline at room temperature was
infused through the thermodilution catheter at a rate
of 50 ml min~' and coronary sinus blood flow (CSBF;
ml.min"1) was calculated according to the formula of
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Ganz et alP*\ Coronary resistance (CR; mmHg.min.ml ')
was calculated according to the following equation:
CR = (MAP-CSP)/CSBF
where MAP = mean aortic pressure (mmHg), CSP = mean
coronary sinus pressure (mmHg). Normalization per 100 g
left ventricular muscle was carried out for coronary sinus
blood flow and coronary resistance using angiographic
mass. In the preoperative patients and in three controls,
mean aortic pressure was determined invasively, whereas
in postoperative patients and four controls in whom sep-
arate right heart catheterization was performed, mean
aortic pressure was calculated as diastolic cuff pressure
plus 33% of pulse pressure amplitude. Coronary sinus
blood flow was determined at rest and after infusion of
0-5 mg.kg"' body weight dipyridamole over 15 min. This
duration of infusion of dipyridamole was chosen in
order to minimize the systemic effects of dipyridamole on
heart rate and blood pressure*261. In no case were adverse
side-effects of dipyridamole encountered.
Coronary flow ratio (CFR) or coronary flow reserve
was calculated as coronary sinus blood flow after dipyrid-
amole infusion divided by the sinus blood flow at rest, and
coronary resistance ratio (CRR) or coronary resistance
reserve as resistance after dipyridamole infusion divided
by resistance at baseline. Coronary venous and arterial
oxygen saturation was measured using an Instrumen-
tation Laboratory System 1302 blood gas analyser, in
order to calculate oxygen content before and after infusion
of dipyridamole. Myocardial oxygen consumption per
100 g left ventricular mass (M V02; ml.min-'. 100 g~') was
determined as the product of the coronary arterio-venous
oxygen content difference and the normalized coronary
sinus blood flow. Because contrast dye (ventriculography,
coronary arteriography) may alter coronary dynamics'271
the baseline value of coronary sinus blood flow was
recorded not earlier than 20 min after any previous
contrast dye injection.
ENDOMYOCARDIAL BIOPSIES
At the preoperative catheterization of the 18 patients
studied postoperatively 2 to 3 left ventricular endo-
myocardial biopsies were obtained using the transseptal
technique1281. The samples were examined microscopi-
cally according to previously described techniques'2*"301.
Muscle fibre diameter (MFD; n) was determined from
several cross-sections at the level of the nucleus with a
mechanical optical pen (MOP, Kontron GmbH, Zurich).
The extent of non-muscular space (index of interstitial
fibrosis, IF; %) was evaluated with the point-counting
method. Fibrous content (FC; g.m"1) of the left ventricle
was calculated
FC = LMMI.IF/100
where LMMI = left ventricular muscle mass index (g.m " ^ ;
IF = relative interstitial fibrosis (%).
Statistics
Values reported are means ± standard deviations,
unless otherwise indicated. Proportional distribution
was tested by the chi-square-test, correlation by linear
regression. Paired Student's /-test was used for comparing
pre- and postoperative data in the patients who died after
valve replacement. For multiple group comparison, one
way analysis of variance was used, followed by a New-
man-Keuls test for comparison between all pairs of means
when an overall significant P value <005 was obtained.
To test baseline data and data after infusion of dipyrida-
mole, a two-way analysis of variance with repeated
measures was performed. If there was a significant 'group-
x time' effect, both timepoints were examined separately,
in order to explore the interaction. Differences between
time points were then tested using the paired Mest.
Results
The three patient groups (preoperative, postoperative
and controls) did not differ with respect to mean age
(58 ±10; 58 ±8; 50+10 years) and mean body surface
area(l-82±013;l-89±014;l-83±011m2). No patients
were anaemic and the mean haemoglobin contents were
similar(13-8±l-3;14-4±0-8;13-9±0-8g.dl-').
The preoperative and postoperative patient groups
comprised a similar distribution of patients with predomi-
nant aortic stenosis (28/37 vs 11 /18, ns) and aortic regurgi-
tation (9/37 vs 7/18, ns). Therefore data from these two
patient groups were pooled for a first analysis of the
results.
The postoperative patients had their diagnostic
preoperative catheterization at our institution. Com-
parison of these preoperative data from postoperative
patients with the preoperative patient gTOup revealed
a comparable severity of aortic valve disease in both
groups. Patients of the preoperative and postoperative
groups with predominant aortic stenosis showed a simi-
lar degree of reduction in the mean aortic valve area
(0-68 ± 0-17 vs 0-73 ± 0-21 cm2; ns) as well as concomitant
aortic regurgitant fraction (0-19 ± 0-19 vs 0-19 ± 0-15; ns).
The preoperative patients with predominant aortic insuf-
ficiency had a slightly greater aortic regurgitant fraction
than postoperative patients prior to aortic valve replace-
ment (0-61 ±008 vs 0-48±006; /><001). No difference
was found for left ventricular end-diastolic pressure,
left ventricular systolic pressure, ejection fraction, left
ventricular muscle mass index and wall thickness. Only
left ventricular end-diastolic volume index was slightly
smaller in the preoperative patient group than in the pre-
operative study of the postoperative patients (126 ±37 vs
158±58ml.m-2;/><005).
HAEMODYNAMIC AND ANGIOGRAPHIC DATA (TABLES 1AND 2)
Systolic aortic pressure was not different in the three
groups (Table 1). Left ventricular end-diastolic pressure
was higher in preoperative patients than controls (17 vs
9 mmHg; P < 0001) and mean pulmonary capillary wedge
pressure was higher in preoperative than postoperative
patients (10 vs 6 mmHg; /><0-01). Left ventricular end-
diastolic volume index was higher and ejection fraction
was lower in preoperative compared with postoperative
Table I Haemodynamic and angiographic data
Preoperative patients
(n = 37)
Postoperative patients
(n=l8)
Controls
(n = 7)
/•values
Preoperative vs
postoperative
Preoperative vs
controls
Postoperative vs
controls
SAP
(mmHg)
130±19
131 ± 16
127±15
ns
ns
ns
LVSP
(mmHg)
191±41
—
122±27
—
<0-01
—
LVEDP
(mmHg)
17±8
—
9±4
—
< 0-001
—
PCP EDVI LMMI h
(mmHg) (mlm"2) (gm"2) (cm)
EF
(dyne.lP.cm *) (dyne.lO\cm 2)
10±5 126±37 160±31 113±014 60± 10
6-4 87±15 99±17 0-93±013 67±8
112±40 79±16 0-71 ±008 68±8
<0001 <0-001 <0001 <005
<0-001 <0001
<0-01
52 ±28
22±13
41 ± 18
<001
478 ±79
354±71
432±91
<000l
ns
<005
Data are means ±80 . /* values were obtained by one-way analysis of variance, ns = not significant. EDVI •= left ventricular end-diastolic volume index; EF = left ventricular ejection fraction; h = left
ventricular end-diastolic wall thickness; LMMI = left ventricular muscle mass index; LVEDP = left ventricular end-diastolic pressure; LVSP = left ventricular peak systolic pressure; PCP = mean
pulmonary capillary wedge pressure; SAP — systolic aortic pressure; S^ — left ventricular circumferential end-diastolic wall stress; S ^ ~ left ventricular circumferential peak systolic wall stress.
Table 2 Haemodynamics and oxygen consumption at rest and after infusion of dipyridamole
HR
(beats.min"1)
R D
MAP
(mmHg)
R D
CSP
(mmHg)
R D
MAP-CSP
(mmHg)
R D
A-VDO,
D
MVO2
(ml.mirr'.lOOg-1)
R D
Preoperative patients
(n-37)
P values RvsD:
Postoperative patients
(n-18)
lvalues RvsD:
Controls
(n-7)
P values R vs D:
73±U 87±14
<0001
74±16 85± 15
<000l
67± 12 87± 16
<0O01
92±11* 88± 12*
<0Ol
100±ll 96±9
<00t
95±9 91 ±6
ns
4±2
3±2
4±1
ns
ns
ng
5±2
3±2
5±2
87±11* 83± 11* 66±4f 43±10*J 11±6 11±5
<001 <0-001 ns
97±12 92±10 64±6 36±12« 12±5 13±5
<001 <0001 ns
91±9 87±6 61 ±5 21 ±5 14±3 13±5
ns <0-001 ns
Data are means ± SD. P values were obtained by paired Mest. ns = not signficant. A-VDO2 = coronary arterio-venous difference of oxygen saturation; CSP = mean coronary sinus pressure; D — after
dipyridamole infusion; HR = heart rate; MAP — mean aortic pressure; MVO2 = myocardial oxygen consumption per minute and per 100 g of left ventricular muscle mass; R — rest.
* - P < 005 preoperative vs postoperative; f - P < 005 preoperative vs controls; % = P< 0-001 preoperative vscontrols;** = /><001 postoperative vs controls (ANOVA).
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Figure I Coronary sinus blood flow (upper panels) and coronary resistance (lower panels) before and after dipyridamole
infusion. Resting (R) total coronary sinus blood flow (CSBF; ml.rain"1) was higher and total coronary resistance (CR;
mmHg.min.ml~1) (left panels) significantly lower in preoperative patients with aortic valve (AVD preop) disease compared
with postoperative patients (AVD postop) and with controls, whereas achieved maximal flow and resistance after dipyrid-
amole infusion (D) did not differ. Conversely, resting coronary sinus blood flow normalized per 100 g left ventricular muscle
mass (CSBF; ml.min"'. 100 g~') and resistance normalized per 100 g left ventricular muscle mass (CR: mmHg.min. 100 g.ml"1)
(right panels) were similar in the three groups. Achieved maximal flow per 100 g left ventricular mass was reduced in
preoperative patients and was restored at least in part in postoperative patients.
patients but differences from controls did not reach stat-
istical significance. Left ventricular muscle mass index
and wall thickness were significantly greater in the pre-
operative patient group than in postoperative patients
and in controls. Between the two latter groups there was a
significant difference in wall thickness (0-93 vs 0-71 cm;
/><001). Left ventricular circumferential end-diastolic
and peak systolic stress were higher in preoperative than
postoperative patients.
After infusion of dipyridamole, heart rate increased in
all three groups (average between 11 and 20 beats min"1)
and mean aortic pressure fell (average 4 mmHg) (Table 2).
There were no differences in myocardial oxygen con-
sumption per lOOg left ventricular muscle mass among
the three patient groups, neither at rest nor after
dipyridamole.
CORONARY DYNAMICS (FIGURES 1-3, TABLE 3)
At rest coronary sinus blood flow was significantly
higher in preoperative than in postoperative patients and
controls (252±99 vs 169±63, P < 0 0 1 ; vs 170±35
ml.min"', F<005) (Fig. 1). Maximally achieved flow,
however, did not differ significantly (416 ± 184vs361 ± 150
vs 488 ±235 ml.min"1). Corresponding coronary resist-
ance was lower in preoperative than in postoperative
patients and controls (0-40 ± 0-18 vs 0-64 ± 0-21, P < 0001;
vs O-55±O11 mmHg.min.mT1, P<00\), while minimal
coronary resistance after administration of dipyridamole
showed no significant differences (0-24 ±012 vs 0-30±
013 vs 0-20±007mmHg.min.mr1). Conversely, cor-
onary flow per lOOg left ventricular muscle mass was
similar at rest within the three groups (90 ±48 vs 94 ±40
vs 121±32ml.min~'.100g~l), but significantly lower
after infusion of dipyridamole in the preoperative
patient group compared with postoperative patients and
controls (144±72 vs 200±92, /><005; vs 336±130
ml.min"1.100 g~\ /><0001) and also between the two
latter groups (P<001). Similarly, at rest no differences
were found among the groups for coronary resist-
ance, when it was normalized to 100 g left ventricular
muscle mass (113±0-41 vs 1-21 ±0-49 vs 0-81 ±0-27
mmHg.min. 100g.ml"1). However, after dipyridamole,
resistance was higher in preoperative and postoperative
patients compared with controls (0-69 ±0-29 vs 0-56 ±
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Figure 2 Coronary flow reserve (upper panel) and coronary vaso-
dilator capacity (lower panel). Patients after aortic valve replace-
ment (AVD postop) showed a distinct improvement of coronary
flow reserve, assessed from coronary flow ratio (CFR), compared
with preoperative patients with aortic valve disease (AVD preop)
Similarly coronary vasodilator capacity, assessed from coronary
resistance ratio (CRR), was improved.
0-25, ns; vs 0-29±012 mmHg.min.100g.mr', /><001,
/ ) <005 respectively).
Coronary flow ratio was significantly lower in pre-
operative patients than in postoperative patients and
controls (l-66±0-44 vs 2-22±0-85, P < 0 0 1 ; vs 2-80±
0-84, /><0-01) and lower in postoperative patients than
controls (p<005) (Fig. 2). Corresponding coronary
resistance ratio was higher in preoperative than in post-
operative patients or controls (0-61 ±017 vs 0-48 ±0-14,
/><005; vs 0-37±0-10, P<00\). Differences between
postoperative patients and controls did not reach statisti-
cal significance. The improvement of coronary flow and
resistance ratio was concomitant with the regression of
left ventricular hypertrophy (Fig. 3), but a significant
linear correlation between the two parameters could not
be established. Furthermore no correlation could be
shown between coronary flow or resistance ratio and left
ventricular systolic pressure, left ventricular end-diastolic
pressure, pulmonary capillary wedge pressure, systolic,
diastolic and mean aortic pressure or ejection fraction for
each group separately or for pooled data.
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Figure 3 Relationship between coronary flow reserve (upper panel)
and coronary resistance ratio (lower panel) to left ventricular muscle
mass index. Patients 30 months after aortic valve replacement ( • )
showed a distinct regression of left ventricular muscle mass index
(LM M I; g.m-1) compared with preoperative patients (O )( /"< 001)
and no significant difference from controls (A). Concomitant with
the regression of muscle mass was the improvement of coronary flow
reserve (CFR) and coronary resistance ratio (CRR) in postoperative
compared with preoperative patients (/"<0-05).
Nine of the 18 postoperative patients showed a normal
flow ratio (;>2-2; group A) and nine an abnormal flow
ratio (<2-2; group B) (Table 3). These two subgroups
showed no differences with respect to preoperative left
ventricular hypertrophy (left ventricular muscle mass
index, wall thickness) and morphometric measurements.
The Doppler echocardiographically determined posto-
perative residual pressure gradient over the aortic pro-
sthesis was similar within these two subgroups (18-6 ±4-9
vs 19-5 ±9-8, ns; n = 8 in each group). No correlations
existed between coronary flow or resistance ratio and pre-
operative ejection fraction, left ventricular end-diastolic
pressure, left ventricular systolic pressure, number of
months after aortic valve replacement, postoperative
residual pressure gradient and extent of regression of left
ventricular muscle mass, the latter being evaluated as
ratio of left ventricular muscle mass index before and after
surgery.
PATIENTS WITH IDENTICAL PERFUSION PRESSURES (TABLE 4)
During maximal vasodilatation, the pressure-flow re-
lationship is steep, and small changes in perfusion
pressure produce large changes in coronary flow and
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Table 3
mem
Group A:
Mean
SD
Group B:
Mean
SD
Morphomelric measurements before
Patient LMMI h(cm)
MFD
(f)
Normal flow reserve after AVR
1
2
3
4
5
6
7
8
9
117
183
194
159
266
236
169
164
135
180
47
0-89
1 38
121
119
114
1-25
0-86
102
103
111
017
28-2
31-4
30-0
291
26-7
30-3
34-6
35-9
30-3
30-7
2-9
Abnormal flow reserve after AVR
1
2
3
4
5
6
7
8
9
116
132
147
175
143
122
187
200
116
149
32
0-98
0-92
0-81
1 25
104
0-82
0-98
116
0-98
0-99
014
32-7
35-9
321
38-6
31 7
32-6
29-7
32-2
35-3
33-4
2-7
aortic valve
IF
(%) (
10
16
16
13
27
18
21
14
17
5
8
12
15
29
12
22
13
13
15
15
6
replace-
FC
11-7
29-3
30-5
20-7
—
63-7
30-4
33-8
190
29-9
15 6
9-3
15-8
221
501
17-7
26-8
24-3
260
17-4
23-3
115
There were no significant differences between the two groups.
AVR = aortic valve replacement; FC = left ventricular fibrous con-
tent; IF = relative interstitial fibrosis; MFD -muscle fibre diameter.
Endomyocardial biopsy of patient 5, group A, was not suitable for
quantitative analysis of relative interstitial fibrosis.
thus flow reserve1151. Perfusion pressures (mean aortic
pressure — mean coronary sinus pressure) after vasodila-
tation with dipyridamole differed significantly between
preoperative and postoperative patients (average differ-
ence of 9mmHg; P<0-05) (Table 2). This could have
contributed to our findings. We therefore performed a
second analysis of the data including only patients having
perfusion pressures after dipyridamole equal to the con-
trols ± 2 SD (Table 4). The same overall result was found
in this subset of patients. In the preoperative patients
coronary sinus blood flow at rest was higher and coronary
resistance was lower (/><005), than in the postoperative
patients, but there was no statistically significant differ-
ence from controls. Coronary flow and resistance after
infusion of dipyridamole were similar in the three groups.
Coronary flow reserve was lower in preoperative than in
postoperative patients (P<005) or controls (P<00l).
Conversely, coronary resistance ratio was higher in the
preoperative than the postoperative group (F<0-05) or
controls (P<00\). Differences between postoperative
patients and controls did not reach statistical significance.
The extent of left ventricular hypertrophy in preoperative
patients and regression of hypertrophy in postoperative
patients of this subgroup were nearly identical to the
values reported for the whole patient population (Tables 1
and 4).
AORTIC STENOSIS VS AORTIC INSUFFICIENCY (FIG. 4)
Coronary flow and resistance ratios of patients with
predominant aortic stenosis and with predominant aortic
insufficiency were nearly identical preoperatively (l-62±
0-40 vs 1-76±0-51, ns; 0-62±017 vs 0-59±015, ns) as
well as postoperatively (2-27±0-87 vs 2-15±0-87, ns vs
0-47 ± 0-15 vs 0-49 ±015, ns) (Fig. 4). Coronary flow ratio
in preoperative patients with predominant aortic stenosis
(n = 28) was lower than in postoperative patients (n = 11)
and in controls (n = 7) (l-62±0-40vs2-27±0-87,/><001;
vs 2-80 ±0-84, P<00\) and, conversely, coronary resist-
ance ratio was higher in preoperative patients with aortic
stenosis than in postoperative patients and controls
(0-62±0-17 vs 0-47±015, P<005; vs 0-37±010,
P<00\). Differences of coronary flow and resistance
reserve between postoperative patients with aortic sten-
osis and controls did not reach statistical significance.
In preoperative patients with predominant aortic insuf-
ficiency (n = 9) coronary flow ratio was significantly lower
(1 76±0-51 vs 2-80±0-84, P<005) and coronary resist-
ance ratio was significantly higher than in controls
(O-59±O15 vs 0-37±010, P<005). In postoperative
patients with predominant aortic insufficiency (n = 7) cor-
onary flow ratio tended to be higher than in preoperative
patients with aortic insufficiency and lower than in con-
trols (1-76 ± 0-51 vs 2-15 ± 0-87, ns; vs 2-80 ± 0-84, ns), and
conversely, coronary resistance ratio in postoperative
patients with predominant aortic insufficiency tended to
be lower than in preoperative patients and higher than in
controls (0-59 ± 0-15 vs 0-49 ±015, ns;vs 0-37 ±0-10, ns),
but differences did not reach statistical significance. The
degree of aortic regurgitation was somewhat higher in
preoperative patients than in postoperative patients,
however, no relationship could be established between
severity of aortic regurgitation and coronary flow or
resistance ratio preoperatively and postoperatively.
Left ventricular hypertrophy, as assessed by left ven-
tricular muscle mass index, was similar in preoperative
patients with predominant aortic stenosis and predomi-
nant aortic insufficiency (155±26 vs 175±40g.m"2,
ns),as was extent of regression of hypertrophy in post-
operative patients with predominant aortic stenosis and
aortic insufficiency (101 ±17 vs98± 19g.m~2, ns).
Discussion
Chronic pressure or volume overload resulting in left
ventricular hypertrophy is associated with a decreased
coronary vasodilator capacity12"81. In patients with aor-
tic stenosis'91 and insufficiency1101 and normal coronary
arteries the decreased coronary vasodilator reserve is
thought to be the underlying cause of ischaemia and
anginal symptoms because it interferes with an adequate
increase of coronary blood flow under stress. In ani-
mal experiments with chronic overload states increased
muscle mass per se has been determined to be the main
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Table 4 Subgroup of patients with identical perfusion pressures after infusion of dipyridamole
MAP-CSP
(mmHg)
R D
CSBF
(ml.min"
R
• ' )
D
CR
(mmHg.min.ml~1)
R D
CFR CRR LMMI
Preoperative 89±8 86±7 248 ± 113 431 ±2O3f 0-43±0-20 0-25±014f I-75±0-46 O-6O±O18 153±28
patients (n = 26)
Postoperative 92±9 88±6 169±68 367±164f 0-61 ±018 0-29±0-13» 2-27±0-95 0-48±O16 100±18
patients (n= 14)
Controls
(n = 7)
Pvalues
Preoperative vs
postoperative
Preoperative vs
controls
9I±9 87±6 170±35 488±235* 0-55±0-ll 0-20±007t 2-80±0-84 0-37±010 79± 16
<0-05
ns
Postoperative vs ns
controls
<(M)5 <005
<001
ns
<005
<001
<0-O01
<0-001
ns
Data are means ±SD. /"values were obtained by one-way analysis of variance. ns = not significant. CFR = coronary flow reserve; CR =
coronary resistance; CRR = coronary resistance ratio; CSBF = coronary sinus blood flow; CSP = mean coronary sinus pressure; D = after
dipyridamole infusion; LMMI = left ventricular muscle mass index; MAP = mean aortic pressure; Rarest. */*<0-01; t = ^*<0-001 (R vsD;
paired /-test).
factor responsible for the derangements of flow and resist-
ance reserve"4-31-321. Wicker et al.[" have shown that in
rats with left ventricular hypertrophy a normal coronary
flow reserve is restored with reversal of hypertrophy.
Regression of left ventricular hypertrophy in man after
successful aortic valve replacement is well known'18'"1. In
order to establish whether, in concert with this regression,
an improvement of coronary reserve occurs, we compared
coronary flow and resistance reserve in 18 patients after
aortic valve replacement whose angiographic mass had
decreased from 165 ± 42 to 99 ± 17 g.m ~2 postoperatively
with that of 37 preoperative patients with aortic valve
disease.
CORONARY FLOW AND RESISTANCE RESERVE
Coronary flow ratio (dipyridamole/rest) was lower in
preoperative than in postoperative patients or controls,
whereas corresponding coronary resistance ratio (dipyrid-
amole/rest) was higher in preoperative patients than in the
other two patient groups (Fig. 2). Differences in the flow
but not in the resistance ratio between patients after aortic
valve replacement and controls were significant. To mini-
mize the influence of perfusion pressure on coronary flow
ratio'15', patients with identical perfusion pressures after
infusion of dipyridamole were examined separately and a
similar result was found. Comparison of patients with
predominant aortic stenosis and patients with predomi-
nant aortic insufficiency showed a similar reduction of
coronary flow reserve preoperatively and a similar en-
hancement postoperatively (Fig. 4). Due to the small
number of patients with predominant aortic insufficiency
studied postoperatively, the extent of this enhancement
is more difficult to judge conclusively in this particular
subgroup.
These data confirm the observations of others1' •2-i-*-'°1
who found a decreased coronary flow reserve in patients
with aortic valve disease. In addition they reveal a major
new finding that, indeed, coronary flow reserve is dis-
tinctly improved after aortic valve replacement. This
improvement accompanied the expected regression of left
ventricular hypertrophy 30 months after aortic valve
replacement. Regression of left ventricular hypertrophy
was not complete and correspondingly coronary flow
reserve was not totally normalized (Fig. 3). However, we
and others'71 did not find a linear correlation between left
ventricular muscle mass and coronary flow reserve. In
experimental aortic valve disease Su-Fan et alP2] have
described an inverse and logarithmic relationship.
POSSIBLE MECHANISMS OF IMPAIRED CORONARY
VASODILATOR CAPACITY
The comparison of preoperative and postoperative
basal coronary flow and flow after maximal vasodilation
with dipyridamole provides important information as to
possible mechanisms responsible for the decreased coron-
ary vasodilator capacity in hypertrophy. In preoperative
patients with aortic valve disease we found a distinct
increase in resting coronary flow and a lower coronary
resistance than in controls or postoperative patients
(Fig. 1), whereas achieved maximal flow and minimal cor-
onary resistance were similar in all three patient groups.
This observation is in agreement with previous studies in
animals*1317--1"*1 and in man[IAIOi which found elevated
basal coronary flow and lower resistance in hypertrophied
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Figure 4 Comparison between patients with aortic stenosis and
patients with aortic insufficiency. Coronary flow reserve (CFR) (up-
per panel) and coronary resistance reserve (CRR) (lower panel) were
similar preoperatively and had changed similarly in postoperative
patients. ( )«=• number of patients in each group.
hearts. It is also in agreement with the data of Kawachi et
al.[i5\ who described a significant decrease of basal cor-
onary flow in patients with aortic insufficiency 7 months
after aortic valve replacement. This finding of an increased
preoperative basal flow implies that a large portion of
coronary reserve is used at rest to cover the demands
caused by the hypertrophied myocardium. It further
implies that the increase in left ventricular muscle mass is
not paralleled by an appropriate change of cross-sectional
area of the vascular bed"3-16-324"61.
The role of a massively altered extravascular com-
ponent (i.e. compressive forces) in reducing coronary
flow reserve is not entirely clear. In isolated, adenosine-
vasodilated, blood perfused canine cardiac preparations,
Harrison et a/.'371 found similar transmural and collateral
coronary resistance per 100 g of normal and hypertrophied
myocardium. In these preparations extravascular com-
pressive forces were minimized and equalized between
normal and hypertrophied hearts. However, others"3-381
have demonstrated an increased minimal vascular resist-
ance in the hypertrophied myocardixun which may be due
in part to extravascular compressive forces. In patients
with supravalvular aortic stenosis and left ventricular
hypertrophy no improvement of coronary vasodilator
capacity occurred when only the intramural compressive
forces were normalized by operation'3'1. In our postoper-
ative patients diastolic (mean pulmonary capillary wedge
pressure, end-diastolic wall stress) and systolic compress-
ive forces (systolic aortic pressure, peak systolic wall
stress) were lowest among the three groups. It is recog-
nized however that both peak systolic and end-diastolic
circumferential wall stress were somewhat underestimated
in the postoperative patients because systolic aortic instead
of systolic left ventricular pressure and mean pulmonary
capillary wedge instead of left ventricular end-diastolic
pressure were used for stress calculations. Nevertheless,
one would have expected an increase in maximal achiev-
able coronary flow after aortic valve replacement if the
preoperative reduction in coronary vasodilator capacity
were due largely to systolic and diastolic compressive
forces. However, in the postoperative group, total maxi-
mal vasodilated flow was even slightly, although not sig-
nificantly, smaller than in the two other groups (Fig. 1).
Thus compressive forces are unlikely to have played a
role in the preoperative reduction of coronary flow and
vasodilator reserve.
The slightly lower maximal flow after dipyridamole
infusion in the postoperative group compared with the
other two groups raises the question of whether, in aortic
valve disease, the longstanding hypertrophy leads to a
structural alteration of the coronary vascular bed. An in-
crease in left ventricular fibrous content has been reported
in aortic valve disease128301. In the present study there was,
however, no correlation between preoperative nonmuscu-
lar interstitial space assessed as relative interstitial fibrosis
or total left ventricular fibrous content and the postoper-
ative coronary flow reserve (Table 3). Although in left
ventricular hypertrophy some enlargement of epicardial
coronary vessels has been demonstrated'16-401, no consist-
ent morphological abnormalities in coronary resistance
vessels, even in hypertrophy due to arterial hypertension,
could be established17401. Thus, it is unlikely that the ob-
served preoperative increase of interstitial fibrous tissue
in aortic valve disease was accompanied by a significant
reduction of the cross-sectional area of the coronary vas-
cular bed either from rarefaction or wall thickening and
luminal narrowing of the resistance vessels.
LIMITATIONS OF THE STUDY
Coronary sinus thermodilution techniques'241 were used
to assess total coronary sinus blood flow. This method is
unable to measure the flow in specific ventricular layers or
regions'411 and may be inaccurate after interventions lead-
ing to coronary sinus reflux1251. In the absence of coronary
artery disease and no known movement of the catheter,
the thermodilution technique is adequate for measuring
relatively slow and large changes of coronary blood
flow*411, as observed in our study.
For the measurement of maximal vasodilator capacity
dipyridamole was used'15-271. It is recognized that dipyrid-
amole at the chosen dose (0-5 mg kg"1) does not always
produce maximal coronary dilation'421. Nevertheless,
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maximal achieved flows at identical perfusion pressures
were similar in the three patient groups (Table 4), suggest-
ing a similar effect of dipyridamole in all groups. The
duration of dipyridamole infusion was 15 min to minimize
the systemic effects on heart rate and blood pressure*2-261. A
fall in blood pressure would have been especially untoward
in the patients with aortic stenosis. It is speculated that the
prolonged administration of dipyridamole was respon-
sible for the generally low coronary flow ratios in the
present study. The average value in the control group was
2-8 with a range of 2-2 to 4-3. These values, considered
normal, are somewhat low, but similar low ratios have
been reported by others, who administered dipyridamole
0-5 and 0-75mg.kg-' i.v. within 4-6 min17-10-42"441. In par-
ticular, Rossen et al.^2] found a coronary flow reserve
in the same range in 8 of 12 normal subjects in whom
coronary vasospasms were excluded by an ergonovine
test.
It is assumed that the control subjects had a normal
coronary reserve, although in patients with ischaemia-
like symptoms and normal coronary arteries a reduced
coronary flow reserve has been reported'43'451. Patients
with true microvascular angina who also had a docu-
mented abnormal vasodilator capacity during dynamic
exercise showed clearly smaller flow ratios than the pres-
ent control subjects'461. Moreover, maximal vasodilated
flow of our control group was similar to previously pub-
lished data on coronary blood flow after i.v. dipyridamole
in normal subjects"0-27-43'441.
Conclusions
In patients with left ventricular hypertrophy, coronary
reserve is reduced due to an elevated basal coronary blood
flow but maximal flow after dipyridamole infusion is
within normal limits. Following aortic valve replacement,
regression of left ventricular hypertrophy is accompanied
by a decrease of resting coronary flow. Coronary flow
reserve is improved because postoperative achieved maxi-
mal flow is essentially unchanged. Similarly coronary
vasodilator capacity, assessed as coronary resistance re-
serve, is enhanced. Diastolic and systolic compressive
forces, as well as structural changes of resistance vessels,
seem to contribute little to altered coronary reserve. Pre-
operative left ventricular muscle mass and morphometric
structure had no predictive value for postoperative
vasodilator capacity.
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